Home › Trial NCT00174369
MEK Inhibitor PD-325901 To Treat Advanced Non-Small Cell Lung Cancer
- Trial IDNCT00174369
- StatusTerminated
- PhasePhase 2
- Study typeInterventional
- SponsorPfizer
- Enrollment34
- Start date2005-11
- ConditionsCarcinoma, Non-Small-Cell Lung
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.